Midazolam (Versed®), the first water-soluble benzodiazepine, has had widespread
acceptance as a parenteral anxiolitic agent. Its antiepileptic properties were studied in adult …

Oromucosal midazolam (Buccolam™) is a benzodiazepine approved for the treatment of
pediatric patients with acute, prolonged, convulsive seizures. This article reviews the …

Sedation is an important aspect of care for critically ill newborns. Proper sedation reduces
stress during procedures such as mechanical ventilation. Midazolam, a short‐acting …

disaster before any sign of trouble was detected. Page 1 536 no cyanosis, change in breath
sounds, or hemodynamic instability. If the pulse oximeter had not been in use, the case could …

Background Because information on the optimal dose of midazolam for sedation of
nonventilated infants after major surgery is scant, a population pharmacokinetic and …

The authors compared the acceptance and efficacy of rectal and nasal administration of
midazolam (MDZ) for premedication. Ninety‐five ASA I and II paediatric patients (8 months to …

Objective. We have used the combination of midazolam, a short-acting benzodiazepine, and
ketamine, a “dissociative anesthetic,” to provide conscious sedation for invasive or lengthy …

Background: Search for an ideal premedicant drug for children is still on. A prospective,
randomized trial was conducted to compare the efficacy of midazolam, triclofos and …

Midazolam can produce antinociceptive effects when used via intrathecal or epidural routes.
Neurotoxicity studies are scanty especially for neonates. The aim of this study was to carry …

Aim: In the present, prospective study, the relation between the levels of midazolam, its two
active metabolites—1‐hydroxy‐midazolam (OH‐midazolam) and 1‐hydroxy‐midazolam …